Pharmacokinetics and intrinsic factor
For successful absorption of cyanocobalamin from the gastrointestinal tract, a specific glycoprotein is critically important — intrinsic factor. It is secreted by parietal cells of the stomach. Upon entering the duodenum, the vitamin binds to this factor to form a single complex, which is then successfully absorbed into the bloodstream.
In the systemic circulation, the drug is transported by special carrier proteins — transcobalamins, which deliver it directly to the bone marrow cells.
An interesting feature of $B_{12}$ pharmacokinetics lies in its colossal reserves. The vitamin depot in a healthy person reaches 2–5 mg, whereas daily losses are only 2–5 mcg. Due to this disproportion, clinically manifest deficiency develops very slowly — several years after the complete cessation of its intake into the body.
Role in hematopoiesis and anemia pathogenesis
In the body, the drug is transformed into an active coenzyme — methylcobalamin. This form triggers a crucial metabolic cascade:
- Ensures the synthesis of tetrahydrofolic acid (the active form of vitamin $B_9$).
- Tetrahydrofolic acid, in turn, participates in the formation of deoxythymidine — a key component of DNA.
When vitamin $B_{12}$ or folic acid is lacking, DNA synthesis is impaired, which primarily affects the rapidly dividing cells of the bone marrow. Erythroblasts continue to grow but lose the ability to undergo normal cell division. As a result, giant immature cells appear in the blood — megaloblasts — as well as large erythrocytes oversaturated with hemoglobin.
The hematological picture in this case is quite specific: the decrease in the erythrocyte count predominates over the drop in hemoglobin levels, and the color index becomes greater than one (> 1). Hyperchromic megaloblastic anemia develops.
Neurological disorders and pernicious anemia
In addition to hematopoiesis, cyanocobalamin is responsible for the synthesis of myelin, the protective sheath of nerve fibers. This is precisely why $B_{12}$-deficiency anemia is always accompanied by damage to the nervous system.
A special form of pathology is pernicious anemia. It occurs not due to a lack of the vitamin in food, but as a result of impaired absorption in the absence of intrinsic factor (for example, against the background of atrophic gastritis, tumors, or gastric resection).
Important clinical nuance: only cyanocobalamin is capable of eliminating neurological symptoms. The administration of folic acid in this case will be completely ineffective for restoring nerve tissue.
Clinical applications
The drug is the agent of choice for treating $B_{12}$-deficiency states.
- Routes of administration: subcutaneously or intramuscularly. In severe pernicious anemia, intravenous administration is permitted.
- Dosing regimen: the standard regimen involves administering 0.1–0.2 mg of the drug every other day (once every 2 days).
- Side effects: allergic reactions, nervous agitation, and cardiac manifestations (tachycardia, precordial pain) are possible.
- Contraindications: erythrocytosis and acute thromboembolism.
It should be remembered that in hyperchromic megaloblastic anemias, iron preparations (e.g., ferrous sulfate) or erythropoietin are not used — they are intended for the treatment of hypochromic anemias and anemias of chronic disease, respectively.
Iatrogenic megaloblastic anemia
Certain medications are capable of disrupting folate metabolism and DNA synthesis, provoking the development of megaloblastic anemia as a side effect (drug toxicity). Such inducing drugs include:
- Folic acid antagonists: the immunosuppressive and antineoplastic agent Methotrexate, the antiprotozoal drug Pyrimethamine, and the potassium-sparing diuretic Triamterene.
- Antiepileptic drugs: for example, Ethosuximide.
Briefly: answers to topical questions
Into what active coenzyme forms does cyanocobalamin convert in the body?
In the body, cyanocobalamin converts into two active coenzyme forms: methylcobalamin and cobamamide.
- Methylcobalamin is necessary for the synthesis of tetrahydrofolic acid, which ensures the formation of deoxythymidine for DNA.
- Cobamamide is an active form involved in metabolic processes, stimulation of protein and carbohydrate synthesis, and the regulation of lipid metabolism.
In which part of the intestine does the absorption of the cyanocobalamin-intrinsic factor complex occur?
The absorption of the cyanocobalamin-intrinsic factor complex is carried out directly into the bloodstream, although the exact section of the intestine is not specified in the materials. It is only known that the vitamin itself forms a complex with intrinsic factor in the duodenum. Intrinsic factor is a glycoprotein secreted by the parietal cells of the stomach and is a critically important condition for the subsequent assimilation of the vitamin.
What biochemical reactions are catalyzed by vitamin B12 coenzymes?
Vitamin B12 coenzyme participates in the transfer of a methyl group during methionine resynthesis: cobalamin is a coenzyme of methionine synthase and transfers a methyl group from folate to homocysteine. Methylcobalamin is also necessary for the formation of tetrahydrofolic acid, which is involved in DNA synthesis.
To remember the absorption chain, imagine a castle (Castle's intrinsic factor) in the stomach that issues a pass to the bloodstream for the vitamin. Without the pass (in gastritis), the vitamin passes by, and pernicious anemia sets in.
Class and exam questions
Why do erythrocytes become abnormally large (megaloblasts) in B12 deficiency?
Due to vitamin deficiency, DNA synthesis necessary for cell division is impaired. The bone marrow cell (erythroblast) grows, accumulates hemoglobin, but cannot divide, turning into a giant megaloblast.
Can pernicious anemia be cured with folic acid alone?
No. Folic acid can partially improve the hematological picture, but it has no effect on myelin synthesis. Neurological disorders will continue to progress, which is why cyanocobalamin itself is vitally necessary.
Why does B12 deficiency develop so slowly?
The body has huge reserves of the vitamin (2–5 mg), while daily losses are only 2–5 mcg. Therefore, years can pass from the moment intake stops until the appearance of the first clinical symptoms.
What else to study on this topic
- Mechanism of action of transcobalamins in blood plasma
- Differential diagnosis of megaloblastic and iron-deficiency anemias
- Biochemical interaction of methylcobalamin and tetrahydrofolic acid
- Pathogenesis of cardiac side effects during cyanocobalamin administration
- Mechanism of development of iatrogenic anemia upon methotrexate intake
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Cyanocobalamin" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Hematopoietic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.